// App-Quantinova.ai

BSH2020‐EP‐063 : The GELOX‐radiotherapy sandwich regime is a highly effective outpatient regimen for limited stage extranodal NK/T‐cell lymphoma nasal type with acceptable toxicity

Researchers

Presenter

  • J. Saeed

Principal Investigators

  • S. Sivabalasingham

  • N. Thakrar

  • S. Mohamadbhai

  • A. Virchis

  • W. Townsend

  • J. Lambert

  • C. McNamara

  • K. Cwynarski

  • K. M. Ardeshna

Medical Centers

  • Hematology

  • Radiation Oncology

  • Phamacy, UCLH, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Oncology (ONC)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Hemophagocytic lymphohistiocytosis

  • Herpes simplex virus infection

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • T-cell lymphoma

  • Genital herpes

  • Tuberculosis

  • Neutropenia

  • Mucositis

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Alanine transaminase

Drug/Treatment

  • Gemcitabine

  • Oxaliplatin

  • Sitavig

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved